CRS: BJMC
Position: Communications Associate
CRS: JHU
Position: Multi-media and Technical Specialist
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
